Abstract
Alterations in platelet reactivity have been posited to underlie the increased vulnerability of depressed patients to IHD, and multiple studies have documented increased platelet activation in patients with major depression. We sought to determine whether treatment with the selective serotonin reuptake inhibitor paroxetine reduces platelet activation in depressed patients in comparison to placebo.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
